Accurate. Rapid. Affordable.

We are committed to advancing tuberculosis (TB) diagnosis with TBFYND, a cutting-edge LAMP-Based TB Testing Solution. Designed for point-of-care TB testing, TBFYND ensures rapid and affordable tuberculosis detection, meeting the needs of rural and underserved communities. Tuberculosis affects over 10 million people globally, with 19 lakh cases annually in India. Timely and accurate TB tests for rural areas are essential to achieve a TB Mukt Bharat and improve public health outcomes.
TBFYND is India’s first CDSCO-approved TB Screening Kit, leveraging LAMP technology for rapid and accurate tuberculosis detection. With 98.73% accuracy, rapid tuberculosis detection in under 60 minutes, and cost-effectiveness, TBFYND redefines affordable TB testing in India. Designed for underserved areas, it ensures reliable, early detection with minimal infrastructure, empowering communities to fight TB effectively and quickly move towards TB eradication


Our Mission
Decentralize TB diagnosis
Our mission is to bring advanced, accurate and affordable TB testing to areas that need it most, ensuring early detection and control of TB in communities that are often underserved. TBFYND empowers governments and healthcare providers to deliver accurate and timely diagnoses, driving forward the fight against TB.



Why TBFYND Stands Out
Faster
Experience the fastest TB testing with TBFYND. Get results within an hour for prompt, effective treatment
Simpler
TBFYND simplifies TB testing with its intuitive design. No complex lab infrastructure is needed—just straightforward, on-the-spot testing that anyone can perform with minimal training.
Better
TBFYND delivers unmatched reliability with high accuracy and sensitivity, detecting nearly all Active TB cases and ensuring error-free results.
Economical
TBFYND combines advanced TB testing with low capital and operational costs, making it a budget-friendly choice for widespread use in resource-constrained settings.
Innovative LAMP Technology
TBFYND leverages WHO-endorsed LAMP technology to provide accurate and efficient TB screening.

Driving Change Through Innovation
Acrannolife Genomics focuses on developing an innovative technology platform for the early detection and monitoring of chronic and infectious diseases such as tuberculosis (TB). Its goal is to disrupt current processes by enabling early detection and decentralized testing, making these solutions accessible to patients worldwide